Evidence map›Paper›PMID 20695799›Full record

ArticleInfection control and hospital epidemiology2010

Multicenter study of Clostridium difficile infection rates from 2000 to 2006.

Erik R Dubberke, Anne M Butler, Deborah S Yokoe, Jeanmarie Mayer, Bala Hota, Julie E Mangino, Yosef M Khan, Kyle J Popovich, Victoria J Fraser

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Infection control and hospital epidemiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Global burden ofJournal of global health · 2019
    Pooled it
  3. Guideline
  4. Pooled it
  5. Dominance of toxigenicFrontiers in microbiology · 2025
    Article
  6. Strategies to preventInfection control and hospital epidemiology · 2023
    Article
  7. Article
  8. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  9. Community-acquired Clostridium difficile infection in Serbian pediatric population.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  10. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Observational
  11. Adherence to clinical practice guidelines for the management of Clostridium difficile infection in Japan: a multicenter retrospective study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Observational
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Postoperative burden of hospital-acquired Clostridium difficile infection.Infection control and hospital epidemiology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Erik R DubberkeDepartment of Medicine, Washington University School of Medicine, Box 8051, 660 South Euclid, St Louis, MO 63110, USA. edubberk@im.wustl.edu
Anne M Butler
Deborah S Yokoe
Jeanmarie Mayer
Bala Hota
Julie E Mangino
Yosef M Khan
Kyle J Popovich
Victoria J Fraser

Funding

Chicago Antimicrobial Resistance and Infection Prevention Epi-Center (CARPE)U01CI000327 · CI · HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI WEINSTEIN, ROBERT A. · 2006 to 2010
$2.5M
Ohio State Health Network Infection Control CollaborativeU01CI000328 · CI · OHIO STATE UNIVERSITY · PI STEVENSON, KURT B · 2006 to 2010
$2.0M
Intermountain Center of Excellence for Infection Prevention StrategiesU01CI000334 · CI · UNIVERSITY OF UTAH · PI SAMORE, MATTHEW H · 2006 to 2010
$2.0M
Eastern Massachusetts Prevention Epicenters Program IIU01CI000344 · CI · HARVARD PILGRIM HEALTH CARE, INC. · PI PLATT, RICHARD · 2006 to 2010
$1.8M
Incidence &Outcomes of SSI After Breast Cancer SurgeryK01AI065808 · NIAID · WASHINGTON UNIVERSITY · PI OLSEN, MARGARET A · 2005 to 2008
$378k
C. DIFFICILE DISEASE IN STEM CELL TRANSPLANT RECIPIENTSK23AI065806 · NIAID · WASHINGTON UNIVERSITY · PI DUBBERKE, ERIK R · 2009 to 2011
$374k
NCPDCID CDC HHS 5U01CI000327NCPDCID CDC HHS 5U01CI000328NCPDCID CDC HHS 5U01CI000344NCPDCID CDC HHS U01 CI000327NCPDCID CDC HHS U01 CI000328NCPDCID CDC HHS U01 CI000334NCPDCID CDC HHS U01 CI000344NCRR NIH HHS K12RR02324901NIAID NIH HHS K01 AI065808NIAID NIH HHS K01AI065808NIAID NIH HHS K23 AI065806NIAID NIH HHS K24AI06779401NIAID NIH HHS L30 AI062141PHS HHS 5U01C1000333PHS HHS UR8/CCU715087-06/1
6 · The paper itself

Abstract

objectiveTo compare incidence rates of Clostridium difficile infection (CDI) during a 6-year period among 5 geographically diverse academic medical centers across the United States by use of recommended standardized surveillance definitions of CDI that incorporate recent information on healthcare facility (HCF) exposure.

methodsData on C. difficile toxin assay results and dates of hospital admission and discharge were collected from electronic databases. Chart review was performed for patients with a positive C. difficile toxin assay result who were identified within 48 hours after hospital admission to determine whether they had any HCF exposure during the 90 days prior to their hospital admission. CDI cases, defined as any inpatient with a stool toxin assay positive for C. difficile, were categorized into 5 surveillance definitions based on recent HCF exposure. Annual CDI rates were calculated and evaluated by use of the chi(2) test for trend and the chi(2) summary test.

resultsDuring the study period, there were significant increases in the overall incidence rates of HCF-onset, HCF-associated CDI (from 7.0 to 8.5 cases per 10,000 patient-days; P < .001); community-onset, HCF-associated CDI attributed to a study hospital (from 1.1 to 1.3 cases per 10,000 patient-days; P = .003); and community-onset, HCF-associated CDI not attributed to a study hospital (from 0.8 to 1.5 cases per 1,000 admissions overall; P < .001). For each surveillance definition of CDI, there were significant differences in the total incidence rate between HCFs.

conclusionsThe increasing incidence rates of CDI over time and across healthcare institutions and the correlation of CDI incidence in different surveillance categories suggest that CDI may be a regional problem and not isolated to a single HCF within a community.

Indexed as

Clostridioides difficileAcademic Medical CentersAdolescentAdultAgedAged, 80 and overClostridium InfectionsCommunity-Acquired InfectionsCross InfectionEnterocolitis, PseudomembranousHumansIncidenceMiddle AgedPatient DischargePopulation SurveillanceUnited States

Identifiers

PMID20695799
PMCPMC3648217

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.